{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:34:47Z","timestamp":1790721287664,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200214"],"award-info":[{"award-number":["82200214"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2025AFD796"],"award-info":[{"award-number":["2025AFD796"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bioorg.2026.109734","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:43:09Z","timestamp":1773074589000},"page":"109734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Epigenetic reprogramming by organic arsenic CZ2 elicits potent antitumor responses in DLBCL through TMS1 restoration"],"prefix":"10.1016","volume":"174","author":[{"given":"Wennei","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bioorg.2026.109734_bb0005","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1093\/annonc\/mdy203","article-title":"Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials","volume":"29","author":"Maurer","year":"2018","journal-title":"Annals of oncology\u202f: official journal of the European Society for Medical Oncology."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109734_bb0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1053\/j.seminhematol.2023.12.001","article-title":"Second-line treatment of diffuse large B-cell lymphoma: evolution of options","volume":"60","author":"Fabbri","year":"2023","journal-title":"Semin. Hematol."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109734_bb0015","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/1878-0261.12744","article-title":"The DNA methylation landscape of hematological malignancies: an update","volume":"14","author":"Blecua","year":"2020","journal-title":"Mol. Oncol."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109734_bb0020","doi-asserted-by":"crossref","first-page":"602","DOI":"10.52586\/4970","article-title":"Methylation alterations and advance of treatment in lymphoma","volume":"26","author":"Liu","year":"2021","journal-title":"Frontiers in bioscience (Landmark edition)."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109734_bb0025","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41571-019-0190-8","article-title":"Emerging epigenetic-modulating therapies in lymphoma","volume":"16","author":"Sermer","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109734_bb0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13148-023-01452-6","article-title":"Clinical advances in epigenetic therapies for lymphoma","volume":"15","author":"Rosenthal","year":"2023","journal-title":"Clin. Epigenetics"},{"issue":"10","key":"10.1016\/j.bioorg.2026.109734_bb0035","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s00018-013-1524-9","article-title":"Epigenetic regulation of ASC\/TMS1 expression: potential role in apoptosis and inflammasome function","volume":"71","author":"Salminen","year":"2014","journal-title":"Cellular and molecular life sciences\u202f: CMLS."},{"key":"10.1016\/j.bioorg.2026.109734_bb0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fcell.2020.00040","article-title":"Dual role of inflammasome adaptor ASC in Cancer","volume":"8","author":"Protti","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109734_bb0045","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1074\/jbc.M109809200","article-title":"Methylation-mediated silencing of TMS1\/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture","volume":"277","author":"Stimson","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109734_bb0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0463.2008.00017.x","article-title":"Prognostic significance of O6-methylguanine DNA methyltransferase and p57 methylation in patients with diffuse large B-cell lymphomas","volume":"117","author":"Lee","year":"2009","journal-title":"APMIS"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109734_bb0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41392-023-01342-6","article-title":"Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109734_bb0060","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.3892\/or.2017.5945","article-title":"The antitumor effects of arsenic trioxide in mantle cell lymphoma via targeting Wnt\/beta-catenin pathway and DNA methyltransferase-1","volume":"38","author":"Li","year":"2017","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109734_bb0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000362683","article-title":"Arsenic trioxide inhibits DNA methyltransferase and restores TMS1 gene expression in K562 cells","volume":"133","author":"Li","year":"2015","journal-title":"Acta Haematol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109734_bb0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12885-023-10612-z","article-title":"Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021","volume":"23","author":"Gill","year":"2023","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.bioorg.2026.109734_bb0075","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1021\/jacs.5b01140","article-title":"Organic arsenicals as efficient and highly specific linkers for protein\/peptide\u2013polymer conjugation","volume":"137","author":"Wilson","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.109734_bb0080","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.freeradbiomed.2019.11.013","article-title":"The novel thioredoxin reductase inhibitor A-Z2 triggers intrinsic apoptosis and shows efficacy in the treatment of acute myeloid leukemia","volume":"146","author":"Zhang","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109734_bb0085","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4161\/cbt.6.11.4829","article-title":"Methylation-induced silencing of ASC\/TMS1, a pro-apoptotic gene, is a late-stage event in colorectal cancer","volume":"6","author":"Riojas","year":"2007","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109734_bb0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3816\/CLC.2006.n.035","article-title":"Prognostic value of apoptosis-associated speck-like protein containing a CARD gene promoter methylation in resectable non-small-cell lung cancer","volume":"8","author":"Zhang","year":"2006","journal-title":"Clin. Lung Cancer"},{"issue":"22","key":"10.1016\/j.bioorg.2026.109734_bb0095","first-page":"6236","article-title":"TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers","volume":"60","author":"Conway","year":"2000","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109734_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-5-28","article-title":"Methylation mediated silencing of TMS1\/ASC gene in prostate cancer","volume":"5","author":"Das","year":"2006","journal-title":"Mol. Cancer"},{"issue":"22","key":"10.1016\/j.bioorg.2026.109734_bb0105","doi-asserted-by":"crossref","first-page":"14698","DOI":"10.1074\/jbc.M901104200","article-title":"Methylation-sensitive regulation of TMS1\/ASC by the Ets factor, GA-binding protein-alpha","volume":"284","author":"Lucas","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109734_bb0110","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1021\/acs.jmedchem.4c02161","article-title":"Structure-activity relationship studies of DNA methyltransferase 1 monovalent degraders","volume":"68","author":"Qian","year":"2025","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109734_bb0115","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nrc3895","article-title":"DNMT3A in haematological malignancies","volume":"15","author":"Yang","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"27","key":"10.1016\/j.bioorg.2026.109734_bb0120","doi-asserted-by":"crossref","first-page":"19079","DOI":"10.18632\/oncotarget.24901","article-title":"An epigenetic regulator-related score (EpiScore) predicts survival in patients with diffuse large B cell lymphoma and identifies patients who may benefit from epigenetic therapy","volume":"9","author":"Szablewski","year":"2018","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.bioorg.2026.109734_bb0125","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jgg.2020.04.006","article-title":"DNA methyltransferases in hematological malignancies","volume":"47","author":"Hoang","year":"2020","journal-title":"J. Genet. Genomics"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109734_bb0130","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1158\/0008-5472.CAN-20-3033","article-title":"Alterations to DNMT3A in hematologic malignancies","volume":"81","author":"Venugopal","year":"2021","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109734_bb0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ncb1087","article-title":"ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway","volume":"6","author":"Ohtsuka","year":"2004","journal-title":"Nat. Cell Biol."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109734_bb0140","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1080\/15548627.2022.2046457","article-title":"Mitochondrial depolarization after acute ethanol treatment drives mitophagy in living mice","volume":"18","author":"Samuvel","year":"2022","journal-title":"Autophagy"},{"issue":"14","key":"10.1016\/j.bioorg.2026.109734_bb0145","first-page":"3893","article-title":"Mechanisms of action of arsenic trioxide","volume":"62","author":"Miller","year":"2002","journal-title":"Cancer Res."},{"issue":"Suppl. 1","key":"10.1016\/j.bioorg.2026.109734_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.7-suppl_1-1","article-title":"Advances in the management of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide","volume":"7","author":"Slack","year":"2002","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109734_bb0155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/cimb46010006","article-title":"Arsenic trioxide decreases lymphangiogenesis by inducing apoptotic pathways and inhibition of important endothelial cell receptors","volume":"46","author":"Hrgovic","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109734_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.moh.0000148552.93303.45","article-title":"Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies","volume":"12","author":"Chou","year":"2005","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bioorg.2026.109734_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.109025","article-title":"Long-term arsenic exposure decreases mice body weight and liver lipid droplets","volume":"192","author":"Lai","year":"2024","journal-title":"Environ. Int."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:46:02Z","timestamp":1774860362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826002701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"alternative-id":["S0045206826002701"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109734","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic reprogramming by organic arsenic CZ2 elicits potent antitumor responses in DLBCL through TMS1 restoration","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109734","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109734"}}